ChemicalBook > CAS DataBase List > Lemborexant

Lemborexant

Product Name
Lemborexant
CAS No.
1369764-02-2
Chemical Name
Lemborexant
Synonyms
E 2006;CS-2189;Dayvigo.;labradon;Lemborexan;Lemborexant;Lemborexant API;lemborexant,E2006;E-2006 Lemborexant;Lemborexant USP/EP/BP
CBNumber
CB72744022
Molecular Formula
C22H20F2N4O2
Formula Weight
410.42
MOL File
1369764-02-2.mol
More
Less

Lemborexant Property

Melting point:
173 - 175°C
Boiling point:
596.1±50.0 °C(Predicted)
Density 
1.347±0.06 g/cm3(Predicted)
storage temp. 
-20°C, Inert atmosphere
solubility 
DMSO (Slightly), Methanol (Slightly)
pka
12.30±0.40(Predicted)
form 
Solid
color 
White to Off-White
InChIKey
MUGXRYIUWFITCP-PGRDOPGGSA-N
SMILES
[C@@H]1(C(NC2=NC=C(F)C=C2)=O)C[C@@]1(COC1=CN=C(C)N=C1C)C1=CC=CC(F)=C1
More
Less

Safety

DEA Controlled Substances
CSCN: 2245
CAS SCH: IV
NARC: N
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Biosynth Carbosynth
Product number
FL103847
Product name
Lemborexant
Packaging
10mg
Price
$245
Updated
2021/12/16
ChemScene
Product number
CS-4320
Product name
Lemborexant
Packaging
5mg
Price
$260
Updated
2021/12/16
AK Scientific
Product number
1887DN
Product name
Lemborexant
Packaging
10mg
Price
$380
Updated
2021/12/16
ChemScene
Product number
CS-4320
Product name
Lemborexant
Packaging
10mg
Price
$450
Updated
2021/12/16
ChemScene
Product number
CS-4320
Product name
Lemborexant
Packaging
25mg
Price
$800
Updated
2021/12/16
More
Less

Lemborexant Chemical Properties,Usage,Production

Description

Lemborexant is a newer orexin receptor antagonist which is submitted to US FDA for review as new drug application for the treatment of insomnia after completing two key Phase 3 studies of lemborexant – SUNRISE 1 (Study 304) and SUNRISE 2 (Study 303).

Chemical Properties

Lemborexant is a white to off-white powder that is practically insoluble in water.

Uses

Lemborexant is a novel orexin receptor antagonist and is used in the treatment of insomnia, characterised by difficulties with sleep onset or sleep maintenance. Orexins are neuropeptides involved in regulating sleep and arousal by promoting wakefulness. Lemborexant blocks the binding of orexins A and B to their receptors 1 and 2 thereby reducing wakefulness and promoting sleep. Suvorexant is the other orexin receptor antagonist marketed in Australia for insomnia.

Pharmacokinetics

Effect of food High-fat & high-calorie meal delay Tmax & reduce Cmax
Tmax 1 to 3 hours
Half-life 17 hours (5 mg) and 19 hours (10 mg)
Metabolism primarily metabolized by CYP3A4
Excretion Urine (29%); feces (57%)

Synthesis

Synthesis route of Lemborexant

Drug interactions

Lemborexant is metabolized by CYP3A4 and is susceptible to interactions with medications such as amiodarone, amlodipine, carbamazepine, clarithromycin, diltiazem, fluoxetine and phenytoin. Lemborexant may affect other medications metabolised by CYP2B6, such as bupropion and methadone. Alcohol should be avoided: a single dose of alcohol can increase lemborexant concentrations up to 70%.

Mode of action

The mechanism of action of lemborexant in the treatment of insomnia is Blocks the binding of wake-promoting neuropeptides orexin A and orexin B to receptors OX1R and OX2R, presumed to suppress wake drive.

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf
https://www.smchealth.org/sites/main/files/file-attachments/dayvigo_for_publish.pdf1592332002
https://www.superiorhealthplan.com/content/dam/centene/Superior/policies/pharmacy-policies/Lemborexant%20(Dayvigo)%20(CP.PMN.233)%20(PDF).pdf

Lemborexant Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lemborexant Suppliers

Nanjing Jiusinuo Biomedical Technology Co., Ltd.
Tel
18014830659
Email
njjsn2023@126.com
Country
China
ProdList
244
Advantage
58
Shanghai Peiling Biological Technology Co., LTD
Tel
17717829335
Email
peilingchem@sina.com
Country
China
ProdList
517
Advantage
58
Hubei Hongfuda Biotechnology Co., Ltd.
Tel
19107255884
Email
259506217@qq.com
Country
China
ProdList
2189
Advantage
58
Shandong Chenxi Pharmaceutical Co., Ltd.
Tel
+86-0531-88803416 13153166250
Fax
0531-88803416
Email
sales@chemedpharma.com
Country
China
ProdList
171
Advantage
58
Sichuan Qingmu Pharmaceutical Co., Ltd.
Tel
02887827187 15881851742
Email
sales@eastonpharma.cn
Country
China
ProdList
60
Advantage
60
NANJING WEDO PHARMATECH CO.,LTD.
Tel
15189836218 15189836218;
Email
wedo-chem@huawe.com
Country
China
ProdList
262
Advantage
58
Henan Inokai New Materials Co., Ltd
Tel
13290191024 13290191024
Email
3887351301@qq.com
Country
China
ProdList
1915
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15727060112
Email
yutianchun2007@126.com
Country
China
ProdList
9856
Advantage
58
Nanjing Yiming Pharmaceutical Technology Co., Ltd.
Tel
19850700912
Email
13851286085@163.com
Country
China
ProdList
500
Advantage
58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1150
Advantage
64
More
Less

View Lastest Price from Lemborexant manufacturers

Shaanxi Dideu New Materials Co. Ltd
Product
Lemborexant 1369764-02-2
Price
US $0.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
10000KGS
Release date
2026-01-14
Xi an Biohorlden Industry Trade Co Ltd
Product
Lemborexant 1369764-02-2
Price
US $0.00-0.00/g
Min. Order
10g
Purity
99%
Supply Ability
50kg
Release date
2025-09-23
Shaanxi Dideu Medichem Co. Ltd
Product
Lemborexant 1369764-02-2
Price
US $0.00-0.00/G
Min. Order
1G
Purity
99%
Supply Ability
KG
Release date
2025-09-10

1369764-02-2, LemborexantRelated Search:


  • (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide
  • E 2006
  • (1R,2S)-2-[(2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL]-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE
  • lemborexant / E-2006, CID 56944144
  • Lemborexant
  • lemborexant,E2006
  • E-2006 Lemborexant
  • 2-((1S,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropyl)-N-(5-fluoropyridin-2-yl)acetamide
  • CS-2189
  • Dayvigo.
  • E-2006; E 2006; E2006; LEMBOREXANT; DAYVIGO.
  • Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-
  • Lemborexant USP/EP/BP
  • Lemborexant API
  • labradon
  • (1S,2R)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-1-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide
  • Lemborexant Impurity 1
  • (1R,2S)-2-[[(2,4-dimethyl-5-pyrimidine)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridyl)cyclopropaneformamide (Leborethen)
  • Lemborexan
  • 1369764-02-2
  • API
  • 1369764-02-2